APEA Pharmacology Women's Health 2026 | Most Tested
Questions & Verified Answers | Latest Update | Graded A+
1. Which of the following statements regarding HRT is true?
A, B, & C are true
Women with an intact uterus should receive estrogen only; progestin
is not necessary
Providers should prescribe the lowest effective dose of HRT for the
shortest duration necessary
A & B are true
The Women's Health Initiative showed that hormone replacement
therapy may be cardioprotective for women over 55 years of age
2. The following are contraindications to the use of combined oral
contraceptives, EXCEPT?
Unexplained vaginal bleeding
Ovarian cancer
Thromboembolism
Smokers older than 35 years old
3. A 52-year-old woman with a history of hypertension is considering hormone
replacement therapy for her menopausal symptoms. Based on the guidelines,
what should be the primary consideration before starting HRT?
Prescribe estrogen alone since she has a uterus.
Ensure she takes HRT for at least 2 years regardless of her health
history.
, Assess her individual risk factors and consider non-hormonal
alternatives if necessary.
Immediately start her on the highest dose of HRT available.
4. If a woman on oral contraceptives reports significant mood swings and
weight gain, what steps should a healthcare provider consider taking?
Increase the dosage of the current contraceptive.
Advise the patient to stop using contraceptives altogether.
Suggest lifestyle changes without adjusting the contraceptive
method.
Evaluate the progestin dosage and consider switching to a
formulation with lower progestin levels.
5. Describe the rationale behind using the lowest effective dose of hormone
replacement therapy (HRT) for menopausal women.
The dose does not affect the risks associated with HRT.
Higher doses are necessary to ensure effectiveness in all women.
Using the lowest effective dose minimizes risks while providing
symptom relief.
HRT should be used indefinitely to prevent all menopausal symptoms.
6. Discuss why the oral route of combined estrogen and progesterone therapy
is linked to a higher risk of deep vein thrombosis compared to other methods.
The oral route has fewer side effects than other methods, making it
safer.
The oral route is linked to a higher risk of DVT due to increased
estrogen levels in the bloodstream, which can promote clot
formation.
, The oral route is less effective than other methods, leading to
increased DVT risk.
The oral route is preferred for all patients, regardless of health history.
7. Which of the following is frequently noted after the insertion of a
levonorgestrel device (Mirena)?
endometrial hyperplasia
increase in PID rates
reduction in menstrual flow
hypermenorrhea
8. Describe how Danazol's mechanism as an androgen may lead to the side
effect of edema.
Danazol can cause fluid retention and swelling due to its
androgenic effects on the body.
Danazol decreases estrogen levels, leading to weight loss.
Danazol has no significant side effects related to fluid retention.
Danazol increases blood flow to the skin, causing breast tenderness.
9. Which symptom is considered normal and does not require immediate
reporting after the implantation of levonorgestrel (Mirena)?
Fever with vaginal discharge
String disappearance
Amenorrhea
Painful intercourse
, 10. Discuss why combined contraceptive patches may have reduced
effectiveness in women over a certain weight.
Women over 200 pounds should avoid using any form of hormonal
contraception.
The effectiveness of combined contraceptive patches is unrelated to
the user's weight.
Combined contraceptive patches are designed to be equally
effective regardless of body weight.
Combined contraceptive patches may have reduced effectiveness
in women over 200 pounds due to pharmacokinetic factors
affecting hormone absorption and metabolism.
11. A patient with endometriosis is experiencing severe symptoms despite
current treatment. How might Danazol be integrated into her management
plan?
Danazol can be used as a first-line treatment for ectopic pregnancy.
Danazol could be added to the treatment regimen to help suppress
estrogen levels and alleviate symptoms.
Danazol should be discontinued to prevent further complications of
endometriosis.
Danazol is not recommended for any hormonal treatment in women.
12. Antifibrinolytic agent for abnormal uterine bleeding only taken during
menses and can be used when trying to conceive
Tranexamic acid
Depot medroxyprogesterone acetate
Levonorgestrel-releasing intrauterine system
Questions & Verified Answers | Latest Update | Graded A+
1. Which of the following statements regarding HRT is true?
A, B, & C are true
Women with an intact uterus should receive estrogen only; progestin
is not necessary
Providers should prescribe the lowest effective dose of HRT for the
shortest duration necessary
A & B are true
The Women's Health Initiative showed that hormone replacement
therapy may be cardioprotective for women over 55 years of age
2. The following are contraindications to the use of combined oral
contraceptives, EXCEPT?
Unexplained vaginal bleeding
Ovarian cancer
Thromboembolism
Smokers older than 35 years old
3. A 52-year-old woman with a history of hypertension is considering hormone
replacement therapy for her menopausal symptoms. Based on the guidelines,
what should be the primary consideration before starting HRT?
Prescribe estrogen alone since she has a uterus.
Ensure she takes HRT for at least 2 years regardless of her health
history.
, Assess her individual risk factors and consider non-hormonal
alternatives if necessary.
Immediately start her on the highest dose of HRT available.
4. If a woman on oral contraceptives reports significant mood swings and
weight gain, what steps should a healthcare provider consider taking?
Increase the dosage of the current contraceptive.
Advise the patient to stop using contraceptives altogether.
Suggest lifestyle changes without adjusting the contraceptive
method.
Evaluate the progestin dosage and consider switching to a
formulation with lower progestin levels.
5. Describe the rationale behind using the lowest effective dose of hormone
replacement therapy (HRT) for menopausal women.
The dose does not affect the risks associated with HRT.
Higher doses are necessary to ensure effectiveness in all women.
Using the lowest effective dose minimizes risks while providing
symptom relief.
HRT should be used indefinitely to prevent all menopausal symptoms.
6. Discuss why the oral route of combined estrogen and progesterone therapy
is linked to a higher risk of deep vein thrombosis compared to other methods.
The oral route has fewer side effects than other methods, making it
safer.
The oral route is linked to a higher risk of DVT due to increased
estrogen levels in the bloodstream, which can promote clot
formation.
, The oral route is less effective than other methods, leading to
increased DVT risk.
The oral route is preferred for all patients, regardless of health history.
7. Which of the following is frequently noted after the insertion of a
levonorgestrel device (Mirena)?
endometrial hyperplasia
increase in PID rates
reduction in menstrual flow
hypermenorrhea
8. Describe how Danazol's mechanism as an androgen may lead to the side
effect of edema.
Danazol can cause fluid retention and swelling due to its
androgenic effects on the body.
Danazol decreases estrogen levels, leading to weight loss.
Danazol has no significant side effects related to fluid retention.
Danazol increases blood flow to the skin, causing breast tenderness.
9. Which symptom is considered normal and does not require immediate
reporting after the implantation of levonorgestrel (Mirena)?
Fever with vaginal discharge
String disappearance
Amenorrhea
Painful intercourse
, 10. Discuss why combined contraceptive patches may have reduced
effectiveness in women over a certain weight.
Women over 200 pounds should avoid using any form of hormonal
contraception.
The effectiveness of combined contraceptive patches is unrelated to
the user's weight.
Combined contraceptive patches are designed to be equally
effective regardless of body weight.
Combined contraceptive patches may have reduced effectiveness
in women over 200 pounds due to pharmacokinetic factors
affecting hormone absorption and metabolism.
11. A patient with endometriosis is experiencing severe symptoms despite
current treatment. How might Danazol be integrated into her management
plan?
Danazol can be used as a first-line treatment for ectopic pregnancy.
Danazol could be added to the treatment regimen to help suppress
estrogen levels and alleviate symptoms.
Danazol should be discontinued to prevent further complications of
endometriosis.
Danazol is not recommended for any hormonal treatment in women.
12. Antifibrinolytic agent for abnormal uterine bleeding only taken during
menses and can be used when trying to conceive
Tranexamic acid
Depot medroxyprogesterone acetate
Levonorgestrel-releasing intrauterine system
